ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
3.600
0.00 (0.00%)
Nov 20, 2024, 4:00 PM EST - Market closed
ImmuCell Employees
As of December 31, 2023, ImmuCell had 79 total employees, including 74 full-time and 5 part-time employees. The number of employees increased by 5 or 6.76% compared to the previous year.
Employees
79
Change (1Y)
5
Growth (1Y)
6.76%
Revenue / Employee
$301,747
Profits / Employee
-$48,241
Market Cap
28.20M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Nortech Systems | 775 |
Pluri | 118 |
IRIDEX | 111 |
DURECT | 58 |
SAB Biotherapeutics | 57 |
Surrozen | 42 |
MiNK Therapeutics | 31 |
OneMedNet | 20 |
ICCC News
- 6 days ago - ImmuCell Corporation (ICCC) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 days ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024 - GlobeNewsWire
- 13 days ago - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024 - GlobeNewsWire
- 6 weeks ago - ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024 - GlobeNewsWire
- 3 months ago - ImmuCell Corporation (ICCC) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024 - GlobeNewsWire
- 3 months ago - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024 - GlobeNewsWire
- 4 months ago - ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024 - GlobeNewsWire